Table 1.
FDA-approved indications and levels of recommendation for BoNT formulations [31].
| FDA approved | CD | BSP | ULS | LLS | |
|---|---|---|---|---|---|
| Ona | CD, BSP, ULS, CM, OAB, AH, strabismus [103] | B | B | A | A |
| Abo | CD, ULS (adults), LLS (children), GL [104] | A | C | A | A |
| Inco | CD, BSP, ULS, GL, sialorrhea [105] | B | B | A | U |
| Rima | CD, sialorrhea [106] | A | U | B | U |
Legend: ONA = onabotulinumtoxinA, ABO = abobotulinumtoxinA, INCO = incobotulinumtoxinA, RIMA = rimabotulinumtoxinB, CD = cervical dystonia, BSP = blepharospasm, ULS = upper-limb spasticity, LLS = lower-limb spasticity, CM = chronic migraine, OAB = overactive bladder, AH = axillary hyperhidrosis, GL = glabellar lines.